Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dierk Scheinert, MD
University of Leipzig
Principal Investigator - Mahmood K Razavi, MD
Vascular and Interventional Specialists of Orange
Principal Investigator - William Gray, MD
Lankenau Heart Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Flinders Medical Center
Bedford Park, Australia
- Sir Charles Gairdner Hospital
Perth, Australia
- Lkh Universitatsklinik Graz
Graz, Austria
- Medizinische Universitat Wien
Vienna, Austria
- Imelda Ziekenhuis
Bonheiden, Belgium
- Zol St. Jan
Genk, Belgium
- University Hospital Gent
Ghent, Belgium
- Klinikum Hoschsauerland Gmbh
Arnsberg, Germany
- Universitats-Herzzentrum Freiburg-Bad Krozingen
Bad Krozingen, Germany
- Srh Klinikum Karlsbad
Karlsbad, Germany
- Universitatsklink Leipzig
Leipzig, Germany
- University Hospital of Tuebingen
Tübingen, Germany
- St. Joseph Hospital
Orange, California, United States
- Bradenton Cardiology Center
Bradenton, Florida, United States
- Cardiovascular Institute of the South
Houma, Louisiana, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- University Hospitals, Cleveland Medical Center
Cleveland, Ohio, United States
- Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, United States
- Pinnacle Health Cardiovascular Institute
Wormleysburg, Pennsylvania, United States
- Greenville Health System
Greenville, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 May 2017
- Primary completion
- 30 Apr 2022
- Completion
- 31 Oct 2025
- Last update posted
- 22 Jun 2023
- Registered enrollment
- 82
- Registry id
- NCT03175744
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.